Skip to main content
SpringerLink
Log in

Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease – a study within the Europe Against Cancer Program

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Szczepanski T, Orfao A, van der Velden VH, San Miguel JF, van Dongen JJ . Minimal residual disease in leukaemia patients. Lancet Oncol 2001; 2: 409–417.

    Article  CAS  Google Scholar 

  2. van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, van Dongen JJ . Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003; 17: 1013–1034.

    Article  CAS  Google Scholar 

  3. Gabert J, Beillard E, van der Velden VHJ, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) of fusion gene transcripts for minimal residual disease detection in leukemia – a Europe Against Cancer Program. Leukemia 2003; 17: 2318–2357.

    Article  CAS  Google Scholar 

  4. Beillard E, Pallisgaard N, van der Velden VHJ, Bi W, Dee R, van der Schoot CE et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe Against Cancer Program. Leukemia 2003; 17: 2474–2486.

    Article  CAS  Google Scholar 

  5. Tanner MA, Berk LS, Felten DL, Blidy AD, Bit SL, Ruff DW . Substantial changes in gene expression level due to the storage temperature and storage duration of human whole blood. Clin Lab Haematol 2002; 24: 337–341.

    Article  CAS  Google Scholar 

  6. Pallisgaard N, Clausen N, Schroder H, Hokland P . Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer 1999; 26: 355–365.

    Article  CAS  Google Scholar 

  7. Tobal K, Newton J, Macheta M, Chang J, Morgenstern G, Evans PA et al. Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse. Blood 2000; 95: 815–819.

    CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. G Barbany

    Present address: Department of Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden

  2. N Pallisgaard

    Present address: Institute of Pathology, Odense University Hospital, Odense, Denmark

  3. E Beillard

    Present address: Department of Biochemistry and Molecular Biology, Hôpital Universitaire Nord – IFR Jean Roche – Université de la Méditerranée, Marseille, France

Authors and Affiliations

  1. Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

    V H J van der Velden, P G Hoogeveen & J J M van Dongen

  2. Department of Laboratory Medicine, Laboratory of Hematology, University Hospital Gasthuisberg, Leuven, Belgium

    N Boeckx

  3. Department of Hematology, Hospital Clínico Universitario, Salamanca, Spain

    M Gonzalez

  4. Department of Pathology, Karolinska, Stockholm, Sweden

    M Malec

  5. Department of Medical Sciences, Uppsala University Hospital, Uppsala, Sweden

    G Barbany

  6. Children's Cancer Research Institute, St Anna Children's Hospital, Vienna, Austria

    T Lion

  7. Clinical and Biological Science, University of Turin, Ospedale San Luigi Gonzaga, Orbassano-Torino, Italy

    E Gottardi

  8. Department of Immuno-hematology, Aarhus University Hospital, Aarhus, Denmark

    N Pallisgaard

  9. Department of Hematology Biology, Institut Paoli Calmettes, France

    E Beillard & J Gabert

  10. Department of Epidemiology and Biostatistics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

    W C J Hop

Authors
  1. V H J van der Velden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Boeckx
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Malec
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G Barbany
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T Lion
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E Gottardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. N Pallisgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. E Beillard
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. W C J Hop
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. P G Hoogeveen
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J Gabert
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. J J M van Dongen
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

on behalf of the Europe Against Cancer Program

Corresponding author

Correspondence to V H J van der Velden.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van der Velden, V., Boeckx, N., Gonzalez, M. et al. Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease – a study within the Europe Against Cancer Program. Leukemia 18, 884–886 (2004). https://doi.org/10.1038/sj.leu.2403309

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403309

  • Springer Nature Limited

This article is cited by

Search

Navigation